Neuropeptide Y directly reduced apoptosis of granulosa cells, and the expression of NPY and its receptors in PCOS subjects
Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neu...
Uloženo v:
| Vydáno v: | Journal of ovarian research Ročník 16; číslo 1; s. 1 - 10 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
31.08.2023
BioMed Central Ltd Springer Nature B.V BMC |
| Témata: | |
| ISSN: | 1757-2215, 1757-2215 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS.
Methods
To simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 µg/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA.
Results
GCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and
Npy
mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects.
Conclusions
These results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY’s function might be involved in follicular developmental failure of PCOS. |
|---|---|
| AbstractList | Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS.BACKGROUNDMost women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS.To simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 µg/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA.METHODSTo simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 µg/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA.GCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects.RESULTSGCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects.These results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY's function might be involved in follicular developmental failure of PCOS.CONCLUSIONSThese results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY's function might be involved in follicular developmental failure of PCOS. Abstract Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS. Methods To simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 µg/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA. Results GCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects. Conclusions These results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY’s function might be involved in follicular developmental failure of PCOS. Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS. Methods To simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 [micro]g/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA. Results GCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects. Conclusions These results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY's function might be involved in follicular developmental failure of PCOS. Keywords: Neuropeptide Y, Neuropeptide, Apoptosis, Hyperandrogenism, Polycystic ovarian syndrome Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS. To simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 [micro]g/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA. GCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects. These results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY's function might be involved in follicular developmental failure of PCOS. BackgroundMost women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS.MethodsTo simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 µg/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA.ResultsGCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects.ConclusionsThese results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY’s function might be involved in follicular developmental failure of PCOS. Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of PCOS. However, the mechanism of follicular developmental arrest in PCOS is not completely understood. The reproductive function of Neuropeptide Y (NPY) in the ovary during folliculogenesis was previously reported; NPY function in apoptosis and proliferation of granulosa cells (GCs) is follicular-stage dependent. The objective of this study was to investigate the role of NPY in ovarian follicular development and the pathogenesis of PCOS. Methods To simulate the PCOS phenotype using a rat model, 21-day old Sprague Dawley rats were implanted with dihydrotestosterone (DHT) capsule (83 µg/day) and euthanized after 28 days. mRNA and protein content of NPY and its receptors were assessed in GCs from DHT treated rats using RT-qPCR and Western blot, respectively. Proliferation and apoptosis of GCs was assessed using Ki67- and TUNEL assays. Finally, NPY levels were measured in human follicular fluid (FF) from matched PCOS and non-PCOS patients using ELISA. Results GCs from DHT treated rats (PCOS-GCs) contained significantly less NPY protein and Npy mRNA by 0.16- and 0.56-fold, respectively, and more NPY receptor type 2 and 5 protein by 2.21- and 3.17-fold, respectively, when compared to sham control. Addition of recombinant NPY to PCOS-GCs culture did not alter Ki67-positive but significantly decreased TUNEL-positive cells by 0.65-fold, but not to baseline levels. There was no significant difference in NPY levels in FF between PCOS and non-PCOS subjects. Conclusions These results indicate that DHT modulates expression of NPY and its receptors, NPY decreases DHT-induced GCs apoptosis. That alterations in NPY’s function might be involved in follicular developmental failure of PCOS. |
| ArticleNumber | 182 |
| Audience | Academic |
| Author | Librach, Clifford L. Tzeng, Chii-Ruey Osuga, Yutaka Salehi, Reza Jahangiri, Sahar Urata, Yoko Tsang, Benjamin Wyse, Brandon A. |
| Author_xml | – sequence: 1 givenname: Yoko surname: Urata fullname: Urata, Yoko organization: Departments of Obstetrics & Gynecology and Cellular & Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, Chronic Disease Program, Ottawa Hospital Research Institute, Critical Care Wing, Department of Obstetrics and Gynecology, the University of Tokyo – sequence: 2 givenname: Reza surname: Salehi fullname: Salehi, Reza organization: Departments of Obstetrics & Gynecology and Cellular & Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, Chronic Disease Program, Ottawa Hospital Research Institute, Critical Care Wing – sequence: 3 givenname: Brandon A. surname: Wyse fullname: Wyse, Brandon A. organization: CReATe Fertility Centre – sequence: 4 givenname: Sahar surname: Jahangiri fullname: Jahangiri, Sahar organization: CReATe Fertility Centre – sequence: 5 givenname: Clifford L. surname: Librach fullname: Librach, Clifford L. organization: CReATe Fertility Centre, Departments of Obstetrics & Gynaecology and Physiology, Institute of Medical Sciences, University of Toronto, Biological Sciences, DAN Women & Babies Research Program, Sunnybrook Research Institute – sequence: 6 givenname: Chii-Ruey surname: Tzeng fullname: Tzeng, Chii-Ruey organization: Center for Reproductive Medicine and Science, Taipei Medical University Hospital – sequence: 7 givenname: Yutaka surname: Osuga fullname: Osuga, Yutaka organization: Department of Obstetrics and Gynecology, the University of Tokyo – sequence: 8 givenname: Benjamin surname: Tsang fullname: Tsang, Benjamin email: btsang@ohri.ca organization: Departments of Obstetrics & Gynecology and Cellular & Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, Chronic Disease Program, Ottawa Hospital Research Institute, Critical Care Wing |
| BookMark | eNp9Uk1rFDEYHqSCbfUPeAoI4sGp-ZqZzEnKorVQ2oJ66Clkknd2s8wmY5IR669vZrfSbpGSQ0LyfCRPnqPiwHkHRfGW4BNCRP0pEoa5KDFlJSa0JqV4URySpmpKSkl18Gj9qjiKcY1xTQVnh8XfS5iCH2FM1gC6QcYG0Gm4RQHMpMEgNfox-Wgj8j1aBuWmwUeFNAxD_IiUMyitAMGfMUCM1rsZdnl9sz2xKWYdncV9iMg6dL24-o7i1K2zR3xdvOzVEOHN_Xxc_Pz65cfiW3lxdXa-OL0odS1oKnXXUoypYLqvlCFC9MC4xsSoqm8w48Cw7ozqMQBm1JC-6XTDOgxti3MqmB0X5ztd49VajsFuVLiVXlm53fBhKVVIVg8gTasaIgyrmlZx3BHVNB1UHRe8EwKzKmt93mmNU7cBo8GloIY90f0TZ1dy6X9Lgnnd8ma-zYd7heB_TRCT3Ng4p6kc-ClKKmrMsWDNbPbuCXTtp-ByVjOq4hTXTDygliq_wLreZ2M9i8rTpqZtzXg92578B5WHgY3VuUy9zft7hPePCCtQQ1pFP0wp_3HcB4odUAcfY4BeapvUDMsOdsgvl3NF5a6iMldUbisq56vTJ9R_QT5LYjtSzGC3hPCQyjOsO1ap-aU |
| CitedBy_id | crossref_primary_10_1016_j_jsbmb_2025_106838 crossref_primary_10_1007_s43032_025_01953_0 crossref_primary_10_7759_cureus_82116 crossref_primary_10_17116_rosakush20242406135 crossref_primary_10_1159_000543877 crossref_primary_10_3390_ani15060845 |
| Cites_doi | 10.1095/biolreprod21.4.773 10.1152/ajpregu.90947.2008 10.1093/humupd/dmn015 10.1210/endo-127-4-1682 10.1371/journal.pone.0236044 10.17219/acem/59380 10.3109/09513599909167578 10.1096/fj.05-4770fje 10.1016/j.npep.2004.07.002 10.1186/s13048-019-0608-z 10.1093/humupd/dmw025 10.1016/j.cell.2009.04.022 10.1006/meth.2001.1262 10.1210/en.2007-0168 10.1016/j.fertnstert.2003.10.004 10.1038/nm1611 10.1016/j.npep.2016.09.002 10.1016/j.repbio.2015.07.004 10.1515/jpem-2021-0487 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 10.1093/humrep/deg277 10.1016/j.gene.2017.08.028 10.1016/j.tem.2015.01.003 10.1038/s41598-020-57672-w 10.1210/en.2012-1424 10.1210/en.2015-1159 10.3389/fendo.2018.00452 10.1016/j.npep.2015.09.010 10.1210/en.2016-1866 10.1093/biolre/ioy096 10.1038/296659a0 10.1016/S0167-0115(98)00074-3 10.1111/j.1365-2826.2011.02126.x 10.1016/j.npep.2018.11.008 10.1210/en.2012-1836 10.1016/j.ejphar.2011.04.039 10.1016/S0303-7207(99)00239-7 10.1056/NEJMcp1514916 10.1016/j.tem.2018.08.005 10.1186/s13048-016-0273-4 10.3109/09513590009167682 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023. BioMed Central Ltd., part of Springer Nature. BioMed Central Ltd., part of Springer Nature 2023 |
| Copyright_xml | – notice: The Author(s) 2023 – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023. BioMed Central Ltd., part of Springer Nature. – notice: BioMed Central Ltd., part of Springer Nature 2023 |
| DBID | C6C AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s13048-023-01261-8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1757-2215 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_d9a718d3579a40b1a77be5b484b88035 PMC10469470 A762963460 10_1186_s13048_023_01261_8 |
| GroupedDBID | --- 0R~ 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HMCUK IAO ICW IEA IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SMD SOJ TR2 TUS UKHRP AAYXX AFFHD CITATION ALIPV 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c682t-cb9200283cf5ad188fe34c01da5f7034e30cbdaf0ee032d1f7bc73b0e99013003 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 7 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001055607700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1757-2215 |
| IngestDate | Mon Nov 10 04:29:09 EST 2025 Tue Nov 04 02:06:14 EST 2025 Fri Sep 05 13:19:12 EDT 2025 Sat Oct 18 23:48:55 EDT 2025 Tue Nov 11 07:35:27 EST 2025 Tue Nov 04 18:40:02 EST 2025 Thu May 22 21:21:19 EDT 2025 Sat Nov 29 02:06:17 EST 2025 Tue Nov 18 21:01:48 EST 2025 Sat Sep 06 07:29:15 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Neuropeptide Y Polycystic ovarian syndrome Hyperandrogenism Neuropeptide Apoptosis |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c682t-cb9200283cf5ad188fe34c01da5f7034e30cbdaf0ee032d1f7bc73b0e99013003 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/d9a718d3579a40b1a77be5b484b88035 |
| PQID | 2865420638 |
| PQPubID | 54971 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d9a718d3579a40b1a77be5b484b88035 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10469470 proquest_miscellaneous_2860408375 proquest_journals_2865420638 gale_infotracmisc_A762963460 gale_infotracacademiconefile_A762963460 gale_healthsolutions_A762963460 crossref_citationtrail_10_1186_s13048_023_01261_8 crossref_primary_10_1186_s13048_023_01261_8 springer_journals_10_1186_s13048_023_01261_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-08-31 |
| PublicationDateYYYYMMDD | 2023-08-31 |
| PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-31 day: 31 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | Journal of ovarian research |
| PublicationTitleAbbrev | J Ovarian Res |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | S Bednarska (1261_CR13) 2017; 26 S Franks (1261_CR5) 2008; 14 PDA Lima (1261_CR11) 2018; 99 Q Wang (1261_CR40) 2013; 154 LE Kuo (1261_CR30) 2007; 13 A Milewicz (1261_CR44) 2000; 14 AV Sirotkin (1261_CR20) 2015; 15 Q Wang (1261_CR38) 2012; 153 S Franks (1261_CR4) 2000; 163 K Loh (1261_CR16) 2015; 26 Y Muroi (1261_CR19) 2016; 59 I Guzelkas (1261_CR24) 2022; 35 KJ Livak (1261_CR41) 2001; 25 L Manneras (1261_CR25) 2009; 296 CR McCartney (1261_CR1) 2016; 375 CR Gotzsche (1261_CR17) 2016; 55 Y Urata (1261_CR21) 2020; 13 B Baranowska (1261_CR23) 1999; 13 1261_CR3 S Franks (1261_CR8) 2018; 9 DR Gehlert (1261_CR14) 2004; 38 JJ Lim (1261_CR34) 2017; 158 KL Campbell (1261_CR39) 1979; 21 L Manneras (1261_CR7) 2007; 148 Q Wu (1261_CR18) 2009; 137 R Salehi (1261_CR35) 2020; 10 E Stener-Victorin (1261_CR37) 2003; 18 J Lewandowski (1261_CR27) 1998; 75–76 K Tatemoto (1261_CR15) 1982; 296 AH Balen (1261_CR2) 2016; 22 F Sun (1261_CR10) 2000; 223 A Hurliman (1261_CR12) 2015; 156 1261_CR43 M Czarnecka (1261_CR31) 2019; 73 B Jana (1261_CR29) 2020; 15 S Movafagh (1261_CR32) 2006; 20 KM Sheppard (1261_CR9) 2011; 23 B Jana (1261_CR26) 2016; 9 X Ding (1261_CR33) 2017; 633 KA Walters (1261_CR6) 2018; 29 R Matyal (1261_CR28) 2011; 665 JC Jorgensen (1261_CR36) 1990; 127 T Scholzen (1261_CR42) 2000; 182 M Gunes (1261_CR22) 2015; 31 |
| References_xml | – volume: 21 start-page: 773 issue: 4 year: 1979 ident: 1261_CR39 publication-title: Biol Reprod doi: 10.1095/biolreprod21.4.773 – volume: 296 start-page: R1124 issue: 4 year: 2009 ident: 1261_CR25 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.90947.2008 – volume: 14 start-page: 367 issue: 4 year: 2008 ident: 1261_CR5 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmn015 – volume: 127 start-page: 1682 issue: 4 year: 1990 ident: 1261_CR36 publication-title: Endocrinology doi: 10.1210/endo-127-4-1682 – volume: 15 issue: 7 year: 2020 ident: 1261_CR29 publication-title: PLoS ONE doi: 10.1371/journal.pone.0236044 – volume: 223 start-page: 295 issue: 3 year: 2000 ident: 1261_CR10 publication-title: Proc Soc Exp Biol Med – volume: 26 start-page: 359 issue: 2 year: 2017 ident: 1261_CR13 publication-title: Adv Clin Exp Med doi: 10.17219/acem/59380 – volume: 13 start-page: 344 issue: 5 year: 1999 ident: 1261_CR23 publication-title: Gynecol Endocrinol doi: 10.3109/09513599909167578 – volume: 20 start-page: 1924 issue: 11 year: 2006 ident: 1261_CR32 publication-title: FASEB J doi: 10.1096/fj.05-4770fje – volume: 38 start-page: 135 issue: 4 year: 2004 ident: 1261_CR14 publication-title: Neuropeptides doi: 10.1016/j.npep.2004.07.002 – volume: 13 start-page: 5 issue: 1 year: 2020 ident: 1261_CR21 publication-title: J Ovarian Res doi: 10.1186/s13048-019-0608-z – volume: 22 start-page: 687 issue: 6 year: 2016 ident: 1261_CR2 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmw025 – volume: 137 start-page: 1225 issue: 7 year: 2009 ident: 1261_CR18 publication-title: Cell doi: 10.1016/j.cell.2009.04.022 – volume: 25 start-page: 402 issue: 4 year: 2001 ident: 1261_CR41 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 148 start-page: 3781 issue: 8 year: 2007 ident: 1261_CR7 publication-title: Endocrinology doi: 10.1210/en.2007-0168 – ident: 1261_CR3 doi: 10.1016/j.fertnstert.2003.10.004 – volume: 13 start-page: 803 issue: 7 year: 2007 ident: 1261_CR30 publication-title: Nat Med doi: 10.1038/nm1611 – ident: 1261_CR43 – volume: 59 start-page: 1 year: 2016 ident: 1261_CR19 publication-title: Neuropeptides doi: 10.1016/j.npep.2016.09.002 – volume: 15 start-page: 257 issue: 4 year: 2015 ident: 1261_CR20 publication-title: Reprod Biol doi: 10.1016/j.repbio.2015.07.004 – volume: 35 start-page: 481 issue: 4 year: 2022 ident: 1261_CR24 publication-title: J Pediatr Endocrinol Metab doi: 10.1515/jpem-2021-0487 – volume: 182 start-page: 311 issue: 3 year: 2000 ident: 1261_CR42 publication-title: J Cell Physiol doi: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 – volume: 18 start-page: 1454 issue: 7 year: 2003 ident: 1261_CR37 publication-title: Hum Reprod doi: 10.1093/humrep/deg277 – volume: 633 start-page: 28 year: 2017 ident: 1261_CR33 publication-title: Gene doi: 10.1016/j.gene.2017.08.028 – volume: 26 start-page: 125 issue: 3 year: 2015 ident: 1261_CR16 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2015.01.003 – volume: 10 start-page: 1021 issue: 1 year: 2020 ident: 1261_CR35 publication-title: Sci Rep doi: 10.1038/s41598-020-57672-w – volume: 153 start-page: 5600 issue: 11 year: 2012 ident: 1261_CR38 publication-title: Endocrinology doi: 10.1210/en.2012-1424 – volume: 156 start-page: 4071 issue: 11 year: 2015 ident: 1261_CR12 publication-title: Endocrinology doi: 10.1210/en.2015-1159 – volume: 9 start-page: 452 year: 2018 ident: 1261_CR8 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2018.00452 – volume: 55 start-page: 79 year: 2016 ident: 1261_CR17 publication-title: Neuropeptides doi: 10.1016/j.npep.2015.09.010 – volume: 158 start-page: 993 issue: 4 year: 2017 ident: 1261_CR34 publication-title: Endocrinology doi: 10.1210/en.2016-1866 – volume: 99 start-page: 838 issue: 4 year: 2018 ident: 1261_CR11 publication-title: Biol Reprod doi: 10.1093/biolre/ioy096 – volume: 296 start-page: 659 issue: 5858 year: 1982 ident: 1261_CR15 publication-title: Nature doi: 10.1038/296659a0 – volume: 75–76 start-page: 239 year: 1998 ident: 1261_CR27 publication-title: Regul Pept doi: 10.1016/S0167-0115(98)00074-3 – volume: 23 start-page: 401 issue: 5 year: 2011 ident: 1261_CR9 publication-title: J Neuroendocrinol doi: 10.1111/j.1365-2826.2011.02126.x – volume: 73 start-page: 11 year: 2019 ident: 1261_CR31 publication-title: Neuropeptides doi: 10.1016/j.npep.2018.11.008 – volume: 154 start-page: 956 issue: 2 year: 2013 ident: 1261_CR40 publication-title: Endocrinology doi: 10.1210/en.2012-1836 – volume: 665 start-page: 19 issue: 1–3 year: 2011 ident: 1261_CR28 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2011.04.039 – volume: 163 start-page: 49 issue: 1–2 year: 2000 ident: 1261_CR4 publication-title: Mol Cell Endocrinol doi: 10.1016/S0303-7207(99)00239-7 – volume: 31 start-page: 903 issue: 11 year: 2015 ident: 1261_CR22 publication-title: Gynecol Endocrinol – volume: 375 start-page: 54 issue: 1 year: 2016 ident: 1261_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMcp1514916 – volume: 29 start-page: 841 issue: 12 year: 2018 ident: 1261_CR6 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2018.08.005 – volume: 9 start-page: 64 issue: 1 year: 2016 ident: 1261_CR26 publication-title: J Ovarian Res doi: 10.1186/s13048-016-0273-4 – volume: 14 start-page: 196 issue: 3 year: 2000 ident: 1261_CR44 publication-title: Gynecol Endocrinol doi: 10.3109/09513590009167682 |
| SSID | ssj0062843 |
| Score | 2.337257 |
| Snippet | Background
Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in... Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in... Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in pathogenicity of... BackgroundMost women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in... Abstract Background Most women with anovulatory infertility show polycystic ovarian syndrome (PCOS), and androgen excess is known as a key factor involved in... |
| SourceID | doaj pubmedcentral proquest gale crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1 |
| SubjectTerms | Analysis Androgens Apoptosis Body fat Cell culture Cell growth Cell proliferation Dihydrotestosterone Enzyme-linked immunosorbent assay Follicular fluid Folliculogenesis Granulosa cells Gynecology Hyperandrogenism Infertility Medicine Medicine & Public Health Metabolism mRNA Neuropeptide Neuropeptide Y Neuropeptides Ovaries Pathogenesis Pathogenicity Phenotypes Polycystic ovarian syndrome Polycystic ovary syndrome Protein folding Proteins Receptor mechanisms Reproductive Medicine RNA Stein-Leventhal syndrome |
| SummonAdditionalLinks | – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELagy4ELrwVRWMBICA5s1DycxDmhsmIFEpRKPLQ9WX5lqVSSUqeI5dcz4yRdhRV74hpPEjue-Sa2Z74h5BmstjKuVBqAEYYBS1MVAAaqIIwl2J4KC-kZb76-z2czfnJSzLv0aNeFVfaY6IG6ZXvGuG0A4YmpNe6YTzCfksXobl-tfwRYQwrPWruCGlfJHhJvhSOyN3_3Yb7okTkDKE76xBmeTRzgN-PQLYwown0YPnBOnsP_IlJfjJ786wjVe6bjm_93TLfIje4PlU5blbpNrtjqDtmfVrA6_35Gn1MfM-o34_fJb8_tscbIGGPpgrYOcnVGN8gIaw2V63rd1G7paF3SU_CL21XtJMXjAndIZWUo_IBS-6sLx61QbDZf-JZl4-A5GHZTbxxdVnR-9PETdVuFW0fuLvly_Obz0dugq-YQ6IzHTaBVEfvKSLpMpYk4L23CdBgZmZYAO8wmoVZGlqG1YRKbqMyVzhMVWjy5SwB87pFRVVf2PqEKFona5kxLCTMaKR5JFpepsTozUazCMYn6aRS6ozrHihsr4Zc8PBPt1AuYeuGnXvAxebm7Z90SfVwq_Rq1YyeJJN3-Qr05FZ3NC1NI8PwmSfNCslBFMs-VTRXjTAFqJumYPEHdEm3G6w5qxBQcFOAiy2AgL7wEgg0MQMsuZwI-A9J2DSQPBpIAEnrY3Gug6EDKiXOFG5Onu2a8EwPvKltvvQzAPE9y6C0f6P1g7MOWavnNE5Vj_EDBcnj7YW8i52__98d9cHlnH5LrsbdZ3Ng_IKNms7WPyDX9s1m6zePO5v8A0X5lOg priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagIMSFRwtiSwEjITjQqHk4iXNcKioOsKxUqNqT5VdKpG2yirOI8uuZ8SaLQgEJrvE4iccz33jsmTEhL8DbyrhSaQBKGAYsTVUAGKiCMJageyospK94c_I-n8346Wkx75PC3BDtPhxJeqT2as2zAwdoyzi8BON_cNeEXyc3Uqw2gz768cmAvxkAbjKkx_y238gE-Ur9V_H4aozkLwel3v4c3f2_P79H7vTrTTpdC8h9cs3W22RnWoOvfXFJX1IfAeq31rfJrQ_9QfsO-e6Ldiwx5MVYekbXlm9xSVss9WoNlctm2TWucrQp6TkYvNWicZLiOYDbp7I2FFaW1H7r42xrJJvNz3xL1Tl4D8bTNK2jVU3nhx-PqVsp3BNyD8jno7efDt8F_TUNgc543AVaFbG_8kiXqTQR56VNmA4jI9MS8ITZJNTKyDK0NkxiE5W50nmiQotHcgmgykOyVTe1fUSoAu9P25xpKWESI8UjyeIyNVZnJopVOCHRMHNC9zXM8SqNhfC-DM_EmtcCeC08rwWfkNebPst1BY-_Ur9BgdhQYvVt_6Bpz0WvzMIUEky6SdK8kCxUkcxzZVPFOFMAh0k6Ic9QnMQ6lXWDIWIKlgcAj2UwkFeeAlEEBqBlnwwBbMB6XCPKvRElaL8eNw8iK3r0cQKzjVmMi9EJeb5pxp4YUVfbZuVpAL95ksPf8pGoj8Y-bqmrL74COQYGFCyHr-8PEv_z639m7u6_kT8mt2OvNLiDv0e2unZln5Cb-mtXufapV_ofRz1Rhw priority: 102 providerName: Springer Nature |
| Title | Neuropeptide Y directly reduced apoptosis of granulosa cells, and the expression of NPY and its receptors in PCOS subjects |
| URI | https://link.springer.com/article/10.1186/s13048-023-01261-8 https://www.proquest.com/docview/2865420638 https://www.proquest.com/docview/2860408375 https://pubmed.ncbi.nlm.nih.gov/PMC10469470 https://doaj.org/article/d9a718d3579a40b1a77be5b484b88035 |
| Volume | 16 |
| WOSCitedRecordID | wos001055607700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: RBZ dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central (NC Live) customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1757-2215 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062843 issn: 1757-2215 databaseCode: RSV dateStart: 20081201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLdgcOCCBgNRGMVICA4smpM4sXPspk0gQYk2mNqT5a9ApZJUdTsx_nqenbQQJuDCJVLil8T2e-_nr-efEXoBo62cK5VF4IQkolmmIsBAFZFEgu8pUsjAeHPxjo3HfDIpyl-O-vIxYS09cFtxh6aQAJ8mzVghKVGxZEzZTFFOFZheGthLCSs2g6kWg3MA3XSzRYbnhw6QmnLIgI8d8jMuvNcMBbb-65h8PU7yt8XS0Aad7qK7XecRj9pM30M3bH0f7Y1qGDh_vcIvcQjnDPPke-h7oN1Y-KAVY_EUt23X_AovPVmrNVgumsWqcTOHmwp_hiZrPW-cxH4m3x1gWRsMfUNsv3WRsrUXG5fTkDJbOfiOj4hplg7PalwefzjHbq38rI57gD6dnnw8fhN1By1EOufJKtKqSMKhRbrKpIk5r2xKNYmNzCpABGpTopWRFbGWpImJK6Y0SxWxflEtBVx4iHbqpraPEFYwftOWUS0lqCBWPJY0qTJjdW7iRJEBijf1LnTHQu4Pw5iLMBrhuWh1JUBXIuhK8AF6vX1n0XJw_FX6yKtzK-n5s8MDsCrRWZX4l1UN0DNvDKLdjLpFATGCtgMgi-ZQkFdBwuMAFEDLbjsDVINn1OpJ7vckwX91P3ljcKLDDyf8fmGa-O7kAD3fJvs3fUxcbZt1kAEE5imD3PKeofbK3k-pZ18Ch7hf2i8og78fbGz659__XLmP_0flPkF3kuCKfmZ-H-2slmv7FN3Wl6uZWw7RTTZh4cqH6NbRybg8Gwbnhrvy7ftyCndn5xc_AMERT9U |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELdGhwQvfA1EYTAj8fHAouXDSZwHhMpg2rSuVGKg9cnYjjMqlaQ0LVD-KP5G7pykU5jY2x54rc9J7P7ud7bvfEfIU9htRVyp0AEldB0WhsoBDlSO60vQPeUm0ma8-dSPBwN-cpIM18jv5i4MhlU2nGiJOi00npHv4A1K5qOBfT395mDVKPSuNiU0KlgcmuUP2LKVrw7ewv_7zPf33h3v7jt1VQFHR9yfO1olvq3Qo7NQph7nmQmYdr1UhhnAn5nA1SqVmWuMG_ipl8VKx4FyDXqQAlACeO4Vss4A7G6HrA8PjoajhvsjIPuguZrDo50SOjAOA8eYJTzp4S3zZ6sEnLcF5-Mz_3LSWtu3d_N_m7Vb5Ea9yqa9Si1ukzWT3yEbvVzOi69L-pzauFfrUNggv2x-kilG96SGjmhl5CdLOsOstialclpM50U5LmmR0VOw7YtJUUqKLo9ym8o8pbCIpuZnHVKco9hgOLIt43kJz8HQoWJW0nFOh7vvP9ByofD4q7xLPl7KLNwjnbzIzX1CFWx0tYmZlhIw4ynuSeZnYWp0lHq-crvEa4AidJ2uHauGTITdtvFIVOASAC5hwSV4l7xc9ZlWyUoulH6D-FtJYqJx-0MxOxU1b4k0kbB6SYMwTiRzlSfjWJlQMc4UMH8QdskWoldUt3ZXdCl6YGSB21kEA3lhJZAwYQBa1vc-YBow9VhLcrMlCUSn280NxkVNtKU4A3iXPFk1Y08MHsxNsbAyYKp4EMPX8pZmtcbebsnHX2yydYyBSFgMb99ulPDs7f-e3AcXf-wWubZ_fNQX_YPB4UNy3bcMgY6KTdKZzxbmEbmqv8_H5exxzTCUfL5s9fwDCiS3EA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgoIkXPjYQhcGMhOCBRcuHkziPZVCBGKViMG1Plr8yKpUkalLE-Ou5c5JCGCAhXutzUl_ufufzfZiQx-BtJVyp2AMl9D0Wx8oDDFSeH0rQPeVn0nW8OT5Mp1N-cpLNfqrid9nufUiyrWnALk1Fs1-ZvFVxnuzXgLyMwwMxFwhPUPhlcoWBJ4NJXe-PjnssTgB8o75U5rfzBubIde2_iM0X8yV_CZo6WzS58f-ruEmud_tQOm4F5xa5ZIstsj0uwAf_fE6fUJcZ6o7ct8jm2y4Av02-uWYeFabCGEtPaWsRF-d0iS1graGyKqumrOc1LXN6BoZwtShrSTE-UO9RWRgKO05qv3b5twWSTWenbmTe1PAczLMplzWdF3R28O6I1iuFZ0X1bfJx8vLDwSuvu77B0wkPG0-rLHRXIek8libgPLcR035gZJwDzjAb-VoZmfvW-lFogjxVOo2UbzFUFwHa3CEbRVnYu4Qq8Aq1TZmWEj5ooHggWZjHxurEBKHyRyTov6LQXW9zvGJjIZyPwxPR8loAr4XjteAj8mw9p2o7e_yV-jkKx5oSu3K7H8rlmeiUXJhMgqk3UZxmkvkqkGmqbKwYZwpgMopHZBdFS7QlrmtsEWOwSACELIGFPHUUiC6wAC27IglgA_bpGlDuDCgBFfRwuBdf0aFSLbAKmYW4SR2RR-thnImZdoUtV44GcJ1HKfxbPhD7wdqHI8X8k-tMjgkDGUvh7Xu99P94-5-Ze-_fyHfJ5uzFRBy-nr65T66FTn_wkH-HbDTLlX1AruovzbxePnRY8B17aF1P |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuropeptide+Y+directly+reduced+apoptosis+of+granulosa+cells%2C+and+the+expression+of+NPY+and+its+receptors+in+PCOS+subjects&rft.jtitle=Journal+of+ovarian+research&rft.au=Urata%2C+Yoko&rft.au=Salehi%2C+Reza&rft.au=Wyse%2C+Brandon+A.&rft.au=Jahangiri%2C+Sahar&rft.date=2023-08-31&rft.issn=1757-2215&rft.eissn=1757-2215&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs13048-023-01261-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13048_023_01261_8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-2215&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-2215&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-2215&client=summon |